home / stock / mor / mor message board
Subject | By | Source | When |
---|---|---|---|
News: $MOR MorphoSys Announces That Its Patents Were | whytestocks | investorshub | 01/26/2019 7:46:16 PM |
Molycor Adds Magnesium Product Specialist To Advisory Committee | abriana90 | investorshub | 01/17/2012 1:32:48 PM |
Molycor Adds Power Consultant To Advisory Committee | abriana90 | investorshub | 01/11/2012 1:54:22 PM |
New web site up and running Looks Great | abriana90 | investorshub | 12/21/2011 3:11:49 PM |
Did you set up this board with the | CleanForMePlease | investorshub | 12/10/2011 3:57:44 AM |
Molycor Assembles Technical Advisory Committee: | TradeBaron | investorshub | 11/30/2011 5:47:04 PM |
Molycor Brings New Experts On Board: | TradeBaron | investorshub | 11/30/2011 5:42:14 PM |
For any of you in the Reno area: | abriana90 | investorshub | 11/28/2011 9:42:16 PM |
Molycor sent me this: | abriana90 | investorshub | 11/28/2011 9:20:39 PM |
NEWS | abriana90 | investorshub | 11/28/2011 1:26:12 PM |
Great News | abriana90 | investorshub | 11/18/2011 2:12:16 PM |
abriana90 | investorshub | 11/15/2011 2:39:34 PM | |
AMY should buy this magnesium property... | Yawn | investorshub | 06/02/2011 11:19:22 AM |
We should put the pink sheets $MLYFF and | Mugato | investorshub | 03/06/2011 4:23:49 PM |
http://www.smartstox.com/interviews/mor/ | Quicksilver1 | investorshub | 02/22/2011 10:33:04 PM |
News, Short Squeeze, Breakout and More Instantly...
MorphoSys AG Company Name:
MOR Stock Symbol:
NASDAQ Market:
2024-04-30 06:15:05 ET Oddo BHF analyst issues NEUTRAL recommendation for MOR on April 30, 2024 04:35AM ET. MOR was trading at $17.36 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy, 1 - Hold, 1 -...
MorphoSys AG (NASDAQ:MOR) is reportedly facing a burgeoning safety concern surrounding pelabresib, an experimental myelofibrosis treatment. My...
– Entered into Business Combination Agreement to be acquired by Novartis for € 68.00 per share in cash, representing a total equity value of € 2.7 billion – Received all mandatory antitrust approvals for the proposed acquisition by Novartis – S...